LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA

DNA Capital Leads ~USD60m Round in Brazilian Drug Prescription Provider Memed (em português)

June 16, 2021
DNA Capital Invests in Memed

DNA Capital led a ~USD60m round in Memed, a Brazilian provider of digital drug prescriptions,  to expand its services from prescriptions to drug fulfillment. DNA Capital invested through a vehicle structured to participate in the round with capital from undisclosed family offices and sovereign wealth funds. DNA Capital led a USD4.5m Series B earlier this year; previous investors include Redpoint eventures, monashees, Qualcomm Ventures and accelerator 21212.

(Brazil Journal) – A DNA Capital, da família Bueno, está investindo R$ 300 milhões na empresa de prescrição médica Memed, uma injeção de capital que permitirá monetizar a base de mais de 120 mil médicos que a startup construiu nos últimos oito anos.

A transação inclui uma pequena parcela secundária que dará saída a todos os investidores — os fundos Redpoint eVentures, Monashees e Qualcomm Ventures, além dos fundadores — e uma primária que vai financiar a criação de um marketplace de medicamentos.

O aporte de hoje é quase 10 vezes o que a Memed havia levantado até agora: R$ 33 milhões em quatro rodadas de capital.

Read more at Brazil Journal.

DNA Capital Leads ~USD60m Round in Brazilian Drug Prescription Provider Memed (em português) was last modified: June 29th, 2021 by cramos
21212BrazilDNA CapitalHealthtechMemedMonasheesQualcomm VenturesRedpoint eVenturesVenture Capital
0
Facebook Twitter Google +

Categories

  • Deals
  • Exits
  • Regulatory
  • M&A
  • New Funds & Firms
  • Partnerships

Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.






Which LAVCA Newsletter would you like to receive?

Tweets

  • Check out this week's top #startup deals and news on emerging tech in #LatAm from LAVCA's #LatAmVentureBulletin:… https://t.co/NOvUvkCflB

    27-Jan-2023

    Reply Retweet Favorite
  • #VC investment in #LatAm in 2022 reached USD7.5b, according to preliminary LAVCA data. Stay tuned for LAVCA’s yea… https://t.co/kAqAuL8Iq5

    23-Jan-2023

    Reply Retweet Favorite
  • January 20 is the last chance to register for "ESG in Venture and Tech Investing," the latest training in the LAVCA… https://t.co/UrbfcPgM7l

    19-Jan-2023

    Reply Retweet Favorite
  • Submissions for the 2023 LAVCA ESG Deal Awards are closing on January 20, 2023. LAVCA's ninth annual showcase will… https://t.co/AIu4FVKxT6

    11-Jan-2023

    Reply Retweet Favorite
  • Thank you for your continued support and commitment to grow private capital investment in Latin America. We look fo… https://t.co/AHA1txwyJZ

    30-Dec-2022

    Reply Retweet Favorite

Keep in touch

Twitter Linkedin Youtube

About LAVCA

 

LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

LAVCA Office

    New York City:
    589 8th Ave, 18th Floor
    New York, NY 10018

Explore LAVCA.org

  • About LAVCA
  • Board, Team, & Advisors
  • Media
  • Contact Us
  • Membership Benefits
  • Members Only Access
  • Education and Programs
  • Research
  • Policy
  • LAVCA VC
  • Contact Us

@2020 - LAVCA. All Rights Reserved.


Back To Top